PeptideNavigator: An interactive tool for exploring large and complex data sets generated during peptide-based drug design projects

There is growing interest in peptide-based drug design and discovery. Due to their relatively large size, polymeric nature, and chemical complexity, the design of peptide-based drugs presents an interesting "big data" challenge. Here, we describe an interactive computational environment, PeptideNavigator, for naturally exploring the tremendous amount of information generated during a peptide drug design project. The purpose of PeptideNavigator is the presentation of large and complex experimental and computational data sets, particularly 3D data, so as to enable multidisciplinary scientists to make optimal decisions during a peptide drug discovery project. PeptideNavigator provides users with numerous viewing options, such as scatter plots, sequence views, and sequence frequency diagrams. These views allow for the collective visualization and exploration of many peptides and their properties, ultimately enabling the user to focus on a small number of peptides of interest. To drill down into the details of individual peptides, PeptideNavigator provides users with a Ramachandran plot viewer and a fully featured 3D visualization tool. Each view is linked, allowing the user to seamlessly navigate from collective views of large peptide data sets to the details of individual peptides with promising property profiles. Two case studies, based on MHC-1A activating peptides and MDM2 scaffold design, are presented to demonstrate the utility of PeptideNavigator in the context of disparate peptide-design projects.

[1]  Evan W. McConnell,et al.  The "PepSAVI-MS" Pipeline for Natural Product Bioactive Peptide Discovery. , 2017, Analytical chemistry.

[2]  F. Clerici,et al.  Non-standard amino acids and peptides: From self-assembly to nanomaterials , 2016 .

[3]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[4]  J. Knight,et al.  Major histocompatibility complex genomics and human disease. , 2013, Annual review of genomics and human genetics.

[5]  Neil D. Rawlings,et al.  Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors , 2015, Nucleic Acids Res..

[6]  K. Janda,et al.  Peptidomimetics and peptide backbone modifications. , 2002, Mini reviews in medicinal chemistry.

[7]  E. Giralt,et al.  Modulating protein-protein interactions: the potential of peptides. , 2015, Chemical communications.

[8]  Hugo O. Villar,et al.  Development of an Informatics Platform for Therapeutic Protein and Peptide Analytics , 2013, J. Chem. Inf. Model..

[9]  Andrew Sewell,et al.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines , 2005, The Journal of experimental medicine.

[10]  Luhua Lai,et al.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..

[11]  Jon Swanson,et al.  Rational, computer-enabled peptide drug design: principles, methods, applications and future directions. , 2015, Future medicinal chemistry.

[12]  Christopher J. White,et al.  Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.

[13]  Irina Vetter,et al.  Pharmacological screening technologies for venom peptide discovery , 2017, Neuropharmacology.

[14]  Michael J. Hartshorn,et al.  AstexViewerTM †: a visualisation aid for structure-based drug design , 2002, J. Comput. Aided Mol. Des..

[15]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[16]  Hiroaki Suga,et al.  Exploring sequence space: harnessing chemical and biological diversity towards new peptide leads. , 2017, Current opinion in chemical biology.

[17]  V. Préat,et al.  Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes , 2017, Expert opinion on drug delivery.

[18]  Gajendra P. S. Raghava,et al.  SATPdb: a database of structurally annotated therapeutic peptides , 2015, Nucleic Acids Res..

[19]  J. Reichert,et al.  Future directions for peptide therapeutics development. , 2013, Drug discovery today.

[20]  M. Karplus,et al.  Effective energy function for proteins in solution , 1999, Proteins.

[21]  Ernst Schönbrunn,et al.  Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX* , 2009, The Journal of Biological Chemistry.

[22]  G. N. Ramachandran,et al.  Stereochemistry of polypeptide chain configurations. , 1963, Journal of molecular biology.